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CD8a+ dendritic cells (DCs) are important in vivo for
cross-presentation of antigens derived from intracel-
lular pathogensand tumors. Additionally, secretionof
interleukin-12 (IL-12) by CD8a+ DCs suggests a role
for these cells in response to Toxoplasma gondii anti-
gens, although it remains unclear whether these cells
are required for protection against T. gondii infection.
Toward this goal, we examined T. gondii infection of
Batf3/ mice, which selectively lack only lymphoid-
resident CD8a+ DCs and related peripheral CD103+
DCs. Batf3/ mice were extremely susceptible to
T. gondii infection, with decreased production of
IL-12 and interferon-g. IL-12 administration restored
resistance in Batf3/ mice, and mice in which IL-12
production was ablated only from CD8a+ DCs failed
tocontrol infection. These results reveal that the func-
tion of CD8a+ DCs extends beyond a role in cross-
presentation and includes a critical role for activation
of innate immunity through IL-12 production during
T. gondii infection.
INTRODUCTION
Although cell-mediated immunity is critical for defense against
the intracellular pathogen Toxoplasma gondii, the precise cells
responsible for initiating the protective innate and adaptive
responses have been difficult to identify. Toxoplasma gondii is
an intracellular protozoan parasite whose elimination requires
production of interferon-g (IFN-g) that activates various cell-
intrinsic antiparasitic defense pathways within infected cells(Yap et al., 2006). The production of IFN-g in T. gondii infection
is dependent on interleukin-12 (IL-12) (Gazzinelli et al., 1993),
and although a number of studies have identified cells capable
of producing IL-12 in response to T. gondii, none has unambig-
uously identified the cellular source of IL-12 in T. gondii infection
relevant to protection in vivo. Several different cells have been
proposed to be important sources of IL-12 during T. gondii
infection, including neutrophils (Bliss et al., 1999, 2000), macro-
phages (Gazzinelli et al., 1994; Robben et al., 2004), plasmacy-
toid dendritic cells (pDCs) (Pepper et al., 2008), conventional
dendritic cells (cDCs) (Liu et al., 2006), and the subset of con-
ventional dendritic cells expressing CD8a (Reis e Sousa et al.,
1997).
Neutrophils have been reported to produce IL-12 in vitro in
response to T. gondii antigens, but it is unlikely that they are
required for protective immunity to T. gondi in vivo. Neutrophils
are rapidly recruited to the peritoneum after infection with high
doses of virulent strains of T. gondii, where they costain for
IL-12 by microscopy (Bliss et al., 1999, 2000). However, influx
of neutrophils is not observed after oral infection with low viru-
lence isolates, which mimics natural routes of infection (Dunay
et al., 2008). Initial in vivo studies in which neutrophils were
depleted with the Ly6C-specific antibody RB6-8C5 suggested
a crucial function for neutrophils in protective immunity against
T. gondii (Sayles and Johnson, 1996; Bliss et al., 2001; Schar-
ton-Kersten et al., 1997b). However, inflammatory monocytes
expressing the same marker Ly6C were later identified (Mordue
and Sibley, 2003; Serbina and Pamer, 2006), and all studies con-
ducted with RB6-8C5 were confounded by dual elimination of
both neutrophils and inflammatory monocytes. In a more recent
study, Dunay et al. (2010) depleted only neutrophils in vivo with
the Ly-6G-specific monoclonal antibody 1A8 and demonstrated
that specific ablation of neutrophils does not increase the sus-
ceptibility of mice to T. gondii infection or alter serum concentra-
tions of IL-12. These recent data argue that neutrophils are lessImmunity 35, 249–259, August 26, 2011 ª2011 Elsevier Inc. 249
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CD8a+ DCs Are Critical in T. gondii Infectionlikely to be a critical in vivo source of IL-12 that is relevant to
protection during T. gondii infection.
Several cells other than neutrophils are viable candidates as
an important source of IL-12 in providing protective immunity
to T. gondii, including monocytes and macrophages. Gazzinelli
et al. (1994) first demonstrated that thioglycolate-elicited perito-
neal macrophages produce IL-12 in response to in vitro stimula-
tion with soluble tachyzoite antigen (STAg). In addition, IL-12
mRNA could be detected in peritoneal exudate cells (PECs) of
mice infected with T. gondii, although individual cell types
from the exudate were not distinguished in this study. Low-
density splenocytes as well as bone marrow-derived macro-
phages (BMMs) are also capable of producing IL-12 in response
to in vitro T. gondii infection (Robben et al., 2004). These studies
demonstrate that activated or in vitro derived macrophages can
produce IL-12 but do not demonstrate an in vivo function for
these cells. In a model of oral infection, Gr1+ inflammatory
monocytes that are recruited to the intestine express IL-12
in vivo (Dunay et al., 2008), although a functional requirement
for IL-12 production by these cells was not demonstrated.
pDCs can also produce IL-12 in response to in vitro infection
by T. gondii (Pepper et al., 2008), although in this study, only
in vitro generated bone marrow-derived pDCs were examined,
and an in vivo requirement for pDCs during T. gondii infection
was not tested. Thus, although various monocyte, macrophage,
and pDC populations can produce IL-12 in response to
T. gondii, their importance as a source of IL-12 for in vivo protec-
tion against T. gondii infection has not been demonstrated and
remains uncertain.
Several studies suggest that conventional DCs are important
as a source of IL-12 in T. gondii infection, but neither excludes
macrophages nor identifies the type of DC that might be respon-
sible for protection. One study used a lineage ablation approach
in which the diphtheria toxin receptor (DTR) was expressed
under control of the Itgax gene promoter (encoding CD11c,
referred to as CD11c-DTR mice), in order to ask whether DCs
were involved in protection against infection by T. gondii (Liu
et al., 2006). Diphtheria toxin (DT) administration in these mice
causes the depletion of CD11c-expressing cells and greatly
increases susceptibility to T. gondii infection. Enhanced sus-
ceptibility was attributed to the depletion of IL-12-producing
DCs, but could also result from loss of macrophages because
CD11c-DTR also depletes several subsets of splenic macro-
phages (Probst et al., 2005). Although transfer of wild-type
DCs, but not IL-12-deficient DCs, did rescue susceptibility in
DT-treated mice, this rescue does not exclude macrophages
as the cell that normally provides protection against T. gondii
infection in vivo. A recent study used selective expression of
Cre recombinase in CD11c-expressing (Itgax-Cre) or Lysozyme
M-expressing (Lyz2-Cre) cells in an attempt to exclusively delete
the toll-like receptor (TLR) adaptor protein MyD88 from DCs and
macrophages, respectively (Hou et al., 2011). Deletion ofMyd88
by CD11c-Cre is sufficient to decrease early IL-12 production
during T. gondii infection and leads to increased susceptibility,
suggesting that IL-12 production by a CD11c-expressing cell is
critical for resistance to T. gondii infection. However, as with
the study by Liu et al. (2006) above, CD11c is expressed by
certain macrophage populations, making it difficult to discern
unambiguously which cell is protective in vivo.250 Immunity 35, 249–259, August 26, 2011 ª2011 Elsevier Inc.A few studies have addressed the potential function of the
CD8a+ DC subset in resistance to T. gondii. Studies of Irf8-
deficient mice have suggested a role for the CD8a+ DC subset
as a protective source of IL-12 in T. gondii infection (Scharton-
Kersten et al., 1997a), but such studies are inconclusive because
these mice harbor additional defects beyond the loss of CD8a+
DCs. Irf8-deficient mice lack development of both CD8a+ DCs
as well as pDCs (Aliberti et al., 2003; Tsujimura et al., 2003),
and additionally have defects in activation of IFN-g-inducible
genes (Tamura and Ozato, 2002). Thus, the increased suscepti-
bility of Irf8/ mice to T. gondii infection (Scharton-Kersten
et al., 1997a) could result from the absence of either CD8a+
DCs or pDCs or from a failure of IFN-g-induced effector mecha-
nisms. Consistent with the latter, administration of IL-12 to
Irf8/ mice produces only a partial and temporary reduction in
susceptibility to T. gondii (Scharton-Kersten et al., 1997a). In
addition, CD8a+ DCs are the major source of IL-12 after intrave-
nous administration of STAg (Reis e Sousa et al., 1997), although
the relevance of this IL-12 to protection against live T. gondii has
not been shown. In summary, although several cell types have
been shown to be capable of producing IL-12 in response to
T. gondii, the important cell type required for in vivo production
of IL-12 after T. gondii infection has not been established.
In this study, we used Batf3/ mice (Hildner et al., 2008) that
are specifically defective in the generation of the CD8a+ DC
subset to address the importance of these cells as a source of
IL-12 during T. gondii infection. Batf3/ mice exhibited
decreased IL-12 and IFN-g production and a dramatically
increased susceptibility to T. gondii, dying within 9 days after
infection. Furthermore, this susceptibility in Batf3-deficient
mice was reversed by administration of IL-12. Finally, we
showed that the CD8a+ DCs were the only cells within the innate
immune system whose IL-12 production was required for resis-
tance to acute T. gondii infection.
RESULTS
Batf3–/– Mice Are Highly Susceptible to T. gondii
Infection
We first compared the survival of wild-type and Batf3/mice to
infection with T. gondii (Figure 1). Intraperitoneal (i.p.) infection
by tachyzoites of the type II avirulent Prugniaud (Pru) strain
of T. gondii revealed a markedly increased susceptibility of
Batf3/ mice relative to wild-type mice (Figure 1A). Whereas
wild-type mice were resistant to T. gondii infection, infection of
Batf3/ mice was uniformly lethal in all genetic backgrounds
tested and led to death within 9 to 10 days after infection. By
using a T. gondii strain harboring a firefly luciferase transgene
reporter, we observed approximately 100-fold increased para-
site burden within 5 days after infection in Batf3-deficient mice
compared to wild-type mice (Figures 1B and 1C). This exponen-
tial parasite growth continued in the Batf3/ mice throughout
the course of infection.
To extend our findings, we challenged wild-type and Batf3/
mice with T. gondii cysts by oral gavage, which simulates the
natural route of infection. Oral challenge of Batf3/ mice
demonstrated a similar susceptibility of these animals to T. gondii
infection, with acute lethality and a failure to control parasite
replication (see Figures S1A and S1B available online). In
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Figure 1. Batf3–/– Mice Rapidly Succumb to Infection with an Avirulent Strain of Toxoplasma gondii
Mice were infected with T. gondii, monitored for survival (A) and parasite burden (B and C), and bled to measure serum cytokines (D and E).
(A) Combined survival data from infected C56BL/6, 129S6/SvEV, and BALB/c wild-type (solid line, n = 30) and Batf3/ (dashed line, n = 29) mice from eight
independent experiments.
(B) Infected wild-type (squares) and Batf3/ (triangles) mice underwent whole-body in vivo imaging throughout the course of infection to measure bio-
luminescence. Data shown are combined parasite burden from infected 129S6/SvEV mice from two independent experiments (n = 5–8 at each time point,
representative of six independent experiments).
(C) Representative bioluminescence images of infected 129S6/SvEV mice throughout the course of infection.
(D and E) Infected 129S6/SvEV wild-type (squares) and Batf3/ (triangles) mice were bled at various time points after infection, and serum was analyzed for
cytokine concentrations. Data represent combined serum concentrations of IL-12p40 (D) and IFN-g (E) through the course of infection from two to three
independent experiments (n = 3–5 at each time point).
(B, D, E) Data are represented as mean ± standard deviation. *0.01 < p < 0.05, **0.001 < p < 0.01, ***p < 0.001.
Immunity
CD8a+ DCs Are Critical in T. gondii Infectionaddition, histological analysis of the spleen and ileum revealed
extensive inflammation and destruction of tissue architecture in
Batf3/ mice 9 days after infection (Figure S1C). However, the
underlying mechanism for this susceptibility is likely to be
complex and will be the focus of future studies. Specifically,
gut CD103+ DCs are also absent in the Batf3/ mice (Edelson
et al., 2010) and may play a role during oral infection. All other
experiments in this study were performed after intraperitoneal
tachyzoite challenge.
To determine whether the crucial effector cytokines IL-12 and
IFN-g were being produced normally in Batf3/ mice, we nextexamined the serum amounts of these cytokines. The IL-12
subunit p40, which is shared with the cytokine IL-23, is used
as the readout for IL-12 in all cases, because IL-23 plays no
role in acute T. gondii infection in the mouse (Lieberman et al.,
2004). IL-12p40 concentrations in serumweremarkedly reduced
in Batf3/mice relative to wild-type mice infected with T. gondii
(Figure 1D). In wild-typemice, serum IL-12p40 began to increase
on day 3 after infection and increased until 7 days after infection.
In contrast, IL-12p40 remained at basal amounts in Batf3/
mice until day 5 after infection, at which point its increase was
significantly reduced relative to wild-type mice for the remainderImmunity 35, 249–259, August 26, 2011 ª2011 Elsevier Inc. 251
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Figure 2. CD8+ T Cell Priming to T. gondii Is Defective in Batf3-Deficient Mice
BALB/c wild-type and Batf3/ mice were infected with T. gondii, sacrificed on day 8 after infection, and analyzed for CD8+ T cell priming by tetramer staining
ex vivo (A–D) and intracellular cytokine staining after peptide restimulation in vitro (E).
(A–C) Absolute numbers of CD8+ tetramer-positive cells in the spleen (A) or peritoneum (B and C) specific for GRA4 (A and B) or GRA6 (C) on day 8 after infection
(n = 3, representative of two independent experiments).
(D) Representative plots of Ld-GRA4 and Ld-GRA6 tetramer staining in the peritoneum, with percentage of total peritoneal cells that are tetramer positive shown.
(E) Absolute numbers of IFN-g-positive CD8+ T cells as measured by intracellular cytokine staining after overnight restimulation of whole splenocytes with the
GRA4 peptide (n = 5).
(B–E) Data are represented as mean ± standard deviation. Not significant (ns): p > 0.05; *0.01 < p < 0.05.
Immunity
CD8a+ DCs Are Critical in T. gondii Infectionof infection. The decrease in IL-12p40 production in Batf3/
mice correlated with significantly reduced concentrations of
serum IFN-g (Figure 1E). In wild-type mice, IFN-g production
began to increase after 4 to 5 days of infection, reaching
a peak at day 8. By contrast, IFN-g showed no increase in
Batf3/ mice for 5 days after infection and showed only a slight
increase on day 7, when it was significantly reduced relative to
wild-type mice.
CD8+ T Cell Priming to T. gondii-Derived Antigens
Is Defective in Batf3–/– Mice
Because CD8a+ DCs are important for generation of virus-
specific CD8+ effector T cells (Hildner et al., 2008), we examined
T cell responses in Batf3/mice after infection by T. gondii (Fig-
ure 2). First, we used two MHCI tetramers to measure the ex-
pansion of CD8+ T cells specific for peptides derived from the
GRA4 and GRA6 dense granule proteins of T. gondii (Frickel
et al., 2008). Tetramer-positive CD8+ T cells were significantly
increased 8 days after infection with T. gondii in the spleen of
wild-type mice, but not in Batf3/ mice (Figure 2A). Tetramer
staining in the peritoneum suggested a similar trend, although252 Immunity 35, 249–259, August 26, 2011 ª2011 Elsevier Inc.the data did not reach significance because of substantial
variability in the observed response in wild-type mice (Figures
2B–2D). Total splenic CD8+ T cell numbers were comparable
between wild-type and Batf3/ mice both before and after
infection (Figure S2B). However, the total number of peritoneal
CD8+ T cells appeared to be highest in infected wild-type mice
(Figure S2A), suggesting local proliferation or recruitment of acti-
vated cells, although again this increase did not reach signifi-
cance as compared to Batf3/ numbers. In addition, by using
the GRA4 peptide to activate splenic antigen-specific CD8+
T cells harvested 8 days after infection, we observed a significant
increase in peptide-induced IFN-g production from wild-type
CD8+ T cells, but not from Batf3/ CD8+ T cells (Figure 2E).
Thus, Batf3/ mice have reduced priming of IFN-g-producing
CD8+ T cells after infection by T. gondii, suggesting that CD8a+
DCs contribute to the priming of CD8+ T cells against this intra-
cellular pathogen.
In summary, Batf3/ mice are highly susceptible to T. gondii
infection compared with wild-type mice and have substantially
reduced IL-12 and IFN-g production during early infection (Fig-
ure 1). In addition, priming of T. gondii-specific CD8+ T cells is
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Figure 3. Splenic CD8a+ Dendritic Cells
Expand after T. gondii Infection in Wild-
Type Mice
129S6/SvEV wild-type and Batf3/ mice were
infected with T. gondii, sacrificed on days 0, 3, 5,
and 7 after infection, and analyzed for changes in
dendritic cell subsets by flow cytometry.
(A) Representative flow cytometry plots gated on
Aqua-negative, MHCII+, CD11c+ conventional
dendritic cells.
(B and C) Absolute numbers of CD8a+ CD103+
DCs (B) and CD11b+ DCs (C) in the spleen of wild-
type (black bars) and Batf3/ (white bars) mice
throughout the course of infection (n = 3, repre-
sentative of two independent experiments). Data
are represented as mean ± standard deviation.
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CD8a+ DCs Are Critical in T. gondii Infectionreduced in infected Batf3/ mice (Figure 2), although the rapid
lethality of T. gondii infection in Batf3/ mice suggests a defect
in an innate rather than adaptive immune response. To further
exclude a role for Batf3 in T cells in the acute lethality observed,
we transferred wild-type purified T cells intoRag2-deficient mice
that were either wild-type or deficient for Batf3. Rag2/ mice
cannot generate T or B cells because of a failure to recombine
and express the required receptors, and therefore the only
T cells present in these mice will be the transferred wild-type
cells. Batf3/Rag2/ animals that were given wild-type
T cells were indistinguishable from Batf3/ mice when exam-
ined for parasite burden after T. gondii infection (Figure S2C),
suggesting that the defect observed in Batf3/ mice is re-
stricted to the innate compartment. Therefore, we next focused
on identifying the cellular source of IL-12 relevant for protection
against T. gondii infection in wild-type mice.
CD8a+ DCs Increase in Early Infection by T. gondii
and Are the Major Producers of IL-12
In uninfected wild-type mice, the CD8a+ subset of conventional
DCs comprises approximately 5%–10% of the total DC com-
partment in the spleen, depending on the mouse strain (Hildner
et al., 2008). CD8a+ DCs also express several surface markers
such as CD103, CD24, and DEC205 that distinguish them from
the newly described CX3CR1+CD8a+ DCs that are distinct from
classical CD8a+ DCs (Bar-On et al., 2010), and one of these addi-
tional markers is used in every experiment to ensure exclusion
of the CX3CR1-expressing subset. The remaining conventionalImmunity 35, 249–259DCs are distributed between those ex-
pressing high or low amounts of CD11b.
After infection by T. gondii, we observed
that the percentage of CD8a+ DCs in
wild-type mice increased to represent
approximately 20% of the total DC com-
partment in the spleen by 7 days after in-
fection (Figure 3A). By contrast, Batf3/
mice lacked CD8a+ DCs as previously
reported (Hildner et al., 2008) and showed
no increase at any time after infection.
Beyond this increase in their percentage,
CD8a+ DCs also increased in absolute
numbers in the spleens of wild-type miceafter T. gondii infection (Figure 3B). By contrast, CD11b+ DCs
were present in similar numbers during all times after T. gondii
infection in both wild-type and Batf3/ mice (Figure 3C;
Figure S3).
Increased numbers of CD8a+ DCs after T. gondii infection
suggests a role in protection against this parasite. Therefore,
production of IL-12p40 by various cell types was measured in
wild-type andBatf3/mice after infection by T. gondii (Figure 4).
We examined day 3 after infection specifically, because we were
interested in cells producing IL-12p40 early enough after infec-
tion that could control the exponential growth of T. gondii
observed as early as day 4 in Batf3/ mice (Figure 1B). We
used intracellular cytokine staining (ICS) to quantify IL-12p40
production by CD8a+ DCs, CD11b+ DCs, pDCs, inflammatory
monocytes, and neutrophils. The percentage of CD8a+ DCs
producing IL-12p40 was increased from basal numbers in unin-
fected mice to approximately 25%–30% at day 3 after infection
(Figure 4A). By contrast, the percentage of CD11b+ DCs that
produced IL-12p40 was not significantly altered by infection,
being approximately 2% to 3% in both infected and uninfected
mice (Figure 4A). Furthermore, inflammatory monocytes, neutro-
phils, and plasmacytoid DCs displayed no induction of IL-12p40
by T. gondii infection (Figure 4B). Accordingly, CD8a+ DCs ex-
pressed the highest amounts of the T. gondii profilin sensor
Tlr11 as compared with a variety of immune cell types (Fig-
ure S4A), suggesting that this cell is optimally poised for sensing
T. gondii and producing initial IL-12 during early infection. In
addition, because the IL-12p40 chain is shared between the, August 26, 2011 ª2011 Elsevier Inc. 253
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Figure 4. CD8a+ Dendritic Cells Are the Major Producers of IL-12 after T. gondii Infection in Wild-Type Mice
129S6/SvEV wild-type and Batf3/ mice were infected with T. gondii, sacrificed on day 3 after infection, and analyzed for the cellular source of IL-12 by
intracellular cytokine staining.
(A) Representative flow cytometry plots gated on MHCII+CD11c+ expressing CD11b+ DCs or CD8a+DEC205+ DCs.
(B)Representative flowcytometry plots gated onLy-6G+CD11b+ neutrophils, Ly-6GLy-6C+CD11b+ inflammatorymonocytes, orCD11c+Bst2+ plasmacytoidDCs.
n = 3, representative of three independent experiments.
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CD8a+ DCs Are Critical in T. gondii Infectioncytokines IL-12 and IL-23, we formally excluded a role for IL-23 in
our system by examining CD8a+ DC induction of the IL-23-
specific subunit p19 and the IL-12-specific subunit p35 upon
infection. Uninfected and infected CD8a+ DCs expressed the254 Immunity 35, 249–259, August 26, 2011 ª2011 Elsevier Inc.IL-12p40 subunit (Figure S4C), as shown above, in conjunction
with the IL-12p35 subunit (Figure S4D), but not the IL-23p19
subunit (Figure S4B), clearly showing production of IL-12 and
not IL-23 by these cells. In addition, expression of IL-12p40
Immunity
CD8a+ DCs Are Critical in T. gondii Infectionwas significantly increased in these cells on day 3 after infection
(Figure S4D). Thus, CD8a+ DCs are the major IL-12-producing
cells in the spleen 3 days after infection by T. gondii.
IL-12 Administration to Batf3–/– Mice Restores IFN-g
Production and Controls T. gondii Infection
If susceptibility of Batf3/ mice to T. gondii results from
decreased IL-12 production caused by the absence of CD8a+
DCs, then administration of IL-12 toBatf3/mice should restore
their resistance to infection. Administration of recombinant
murine IL-12 to wild-type mice had no impact on their suscepti-
bility to infection by T. gondii (Figure 5A). In contrast, administra-
tion of IL-12 to Batf3/ mice during the first 5 days of infection
dramatically reversed their susceptibility, promoting their
survival after infection for more than 60 days. Moreover, IL-12
treatment of Batf3/ mice reduced their pathogen burden
compared to untreated Batf3/ mice (Figures 5B and 5C).
Because reduced IL-12 in Batf3/ mice may cause suscepti-
bility to T. gondii by lowering early IFN-g production, we asked
whether IL-12 administration to Batf3/ mice also restored
normal IFN-g production during infection (Figures 5D–5G).
IL-12 administration to wild-type mice did not influence serum
IFN-g concentrations at day 4 after infection (Figure 5D).
However, IL-12 administration to Batf3/ mice significantly
increased serum IFN-g on day 4, which approximated amounts
found in infected wild-type mice. The IFN-g induced by IL-12
in Batf3/ mice appeared to arise from several cell types
(Figures 5E–5G; Figures S5A–S5C). NK, CD4+, and CD8+
T cells from infected wild-type mice produced IFN-g by ICS on
day 3 when examined immediately ex vivo, but NK, CD4+, and
CD8+ T cells from infected Batf3/ mice were devoid of IFN-g
at this time. However, administration of IL-12 to Batf3/ mice
infected with T. gondii substantially restored IFN-g production
by all three cell types. In summary, IL-12 administration to
Batf3/ mice reverses their susceptibility to T. gondii infection,
decreases pathogen burden, and increases IFN-g production by
natural killer cells and T lymphocytes.
CD8a+ DCs Are the Only Cells whose IL-12 Production
Is Required to Control Acute T. gondii Infection
The fact that CD8a+ DCs are amajor source of IL-12 during acute
T. gondii infection does not prove that they are the only source of
IL-12 capable of controlling infection, and their requirement for
protection against acute infection may derive from different,
unknown functions. To test whether IL-12 production by
CD8a+ DCs is relevant for resistance to acute T. gondii infection,
wegeneratedmixedchimerasbyusingbonemarrow (BM)derived
from Il12a/ (encoding IL-12p35 subunit) and Batf3/ mice.
CD8a+ DCs can develop from Il12a/ BM but not Batf3/ BM.
This protocol allows the generation of chimeras in which CD8a+
DCs now develop but are unable to produce IL-12, although all
other immune cell types can produce IL-12. If CD8a+ DCs are
solely required for providing an early source of IL-12, then the
mixed chimeras will remain susceptible to infection.
For this experiment, several other chimeras are necessary as
controls. We generated chimeras receiving only wild-type,
Batf3/, or Il12a/ BM, as well as mixed chimeras receiving
wild-type BM with either Batf3/ or Il12a/ BM (Figure 6; Fig-
ure S6A). Chimeras of all six types were infected with T. gondiiand analyzed along with nonchimera controls for survival and
parasite burden. First, chimeras reconstituted with wild-type
BM controlled parasite numbers as expected, with burden
equivalent to wild-type nonchimeric mice (Figures 6B and 6C).
The majority of these mice also survived acute infection (Fig-
ure 6A). Chimeras reconstituted either with Batf3/ or Il12a/
BM succumbed to acute infection as expected and showed
high parasite burdens, each approximately 100-fold higher that
wild-type, reflecting the phenotype of the respective mutant
nonchimeric mice (Figures 6A–6C; Figure S6A).
We next examined mixed bone marrow chimeras. Mixed
chimeras reconstituted with wild-type plus Batf3/ BM or
Il12a/ BM showed low parasite burdens, equivalent to wild-
type mice and chimeras reconstituted with wild-type BM (Fig-
ures 6B and 6C; Figure S6A). In both of these mixed chimeras,
only half of the cells would harbor a defect, and the other half
would be normal. Thus, a half cell complement of normal cells
appears sufficient for normal control of parasite burden.
Finally, we analyzed chimeras reconstituted with a mixture of
Batf3/ and Il12a/ BM (Figure 6; Figure S6A). In these
chimeras, CD8a+ DCs develop only from Il12a/ BM, whereas
all other cells develop from both IL-12-sufficient and Il12a/
BM. Thus, in these chimeras, the CD8a+ DCs uniformly lack the
capacity to produce IL-12, whereas all other cell types retain the
capacity to produce IL-12. These mixed chimeras were highly
susceptible to infection and had extremely high parasite burden,
comparable to nonchimeric Batf3/ mice (Figures 6A–6C; Fig-
ure S6A). These results indicate that the CD8a+ DCs are the only
cells whose IL-12 production is sufficient for controlling parasite
burden and maintaining resistance to acute T. gondii infection.
DISCUSSION
The present study identifies a second critical activity for the
CD8a+ DC subset beyond its recognized role in priming CD8+
T cell responses to viruses. Previously, we demonstrated that
the CD8a+ DC is critical in promoting effective CTL responses
against West Nile virus and is crucial in that setting for cross-
presentation of virus-derived antigens involved in immune ac-
tivation (Hildner et al., 2008). Additionally, priming of Sendai
virus-specific CTLs has also been shown to be dependent on
the peripheral cross-presentingCD103+DC,which is also absent
in the Batf3-deficient mice (Edelson et al., 2010). Here we show
that priming of CD8+ T cells to endogenous T. gondii antigen is
also defective in Batf3-deficient mice early after infection. Addi-
tionally, wedemonstrate that the sameDCsubset provides a crit-
ical but distinct function by acting as an important early sensor of
infection by T. gondii. The inability of mixed chimeras generated
from bone marrow of Il12a-deficient and Batf3-deficient mice to
control T. gondii infection demonstrates that the CD8a+ DC is
the only cell whose IL-12 production significantly contributes to
reducing pathogen burden during acute infection. Thus, in each
of these pathogen settings, the CD8a+ dendritic cell is unique in
its provision of effective defense mechanisms, but the mecha-
nisms by which this cell mediates defenses are different.
Mice lacking Batf3 show a very selective elimination of the
subset of DCs characterized by the selective expression of
CD8a, CD103, DEC205, CLEC9a, and Langerin (Hildner et al.,
2008; Edelson et al., 2010; Sancho et al., 2009). In uninfectedImmunity 35, 249–259, August 26, 2011 ª2011 Elsevier Inc. 255
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Figure 5. Administration of IL-12 Rescues Batf3-Deficient Mice during T. gondii Infection
129S6/SvEV mice were infected with T. gondii and injected with saline or 0.5 mg of recombinant murine IL-12 on days 0, 1, 2, 3, and 4 after infection.
(A) Survival data from infected mice (WT, solid black line; WT + IL-12, solid red line; Batf3/, dashed black line; Batf3/ + IL-12, dashed red line) (n = 3–5,
representative of three independent experiments).
(B) Combined parasite burden from whole body in vivo bioluminescence imaging of infected mice (WT, black squares; WT + IL-12, red squares; Batf3/, black
triangles;Batf3/+ IL-12, red triangles) from two independent experiments (n = 3–8 at each time point, representative of four independent experiments). Data are
represented as mean ± standard deviation.
(C) Representative bioluminescence images of infected mice throughout the course of infection.
(D) Serum concentrations of IFN-g on day 4 after infection (n = 4–5).
(E–G) Absolute numbers of IFN-g-positive NK (E), CD4+ T (F), and CD8+ T (G) cells in the spleen directly ex vivo on day 3 after infection asmeasured by intracellular
cytokine staining (n = 3).
(D–G) Horizontal lines represent the geometric mean. Not significant (ns): p > 0.05, *0.01 < p < 0.05, **0.001 < p < 0.01, ***p < 0.001.
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CD8a+ DCs Are Critical in T. gondii Infectionmice, DCs of this subset comprise between 5% and 10% of the
total DC compartment and are distributed both to the secondary
lymphoid organs (including spleen and lymph nodes), where they256 Immunity 35, 249–259, August 26, 2011 ª2011 Elsevier Inc.express CD8a as a marker, as well as to various peripheral
tissues (such as the dermis, lung, and lamina propria), where
they lack CD8a but express the remaining markers (Edelson
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Figure 6. CD8a+ Dendritic Cells Are the Only Cells whose IL-12
Production Is Protective against Acute T. gondii Infection
BALB/c chimeras and control nonchimeric mice were infected with T. gondii
and monitored for survival (A) and parasite burden (B–C).
(A) Survival data from nonchimeric wild-type (black line) and Batf3/ (red line)
mice were compared to lethally irradiated recipients that received only wild-
type (purple line) or Batf3/ (green line) BM or a 1:1 mixture of wild-type with
Batf3/ BM (orange line) or Il12a/ with Batf3/ BM (blue line) (n = 5–6,
representative of two independent experiments).
(B and C) Parasite burden (B) and representative images (C) on day 7 after
infection from the groups in (A).
(B) Horizontal lines represent the geometric mean. **0.001 < p < 0.01,
***p < 0.001.
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CD8a+ DCs Are Critical in T. gondii Infectionet al., 2010). Batf3-deficient mice do not exhibit any apparent
global immunodeficiency, being generally healthy in the absence
of overt infection and generating essentially normal CD4+ T cells
responses and antibody responses to viruses including West
Nile virus (Hildner et al., 2008). Because control of many patho-
gens can be mediated by one of several immune effector mech-
anisms, the intact CD4+ T cell responses and antibody
responses in Batf3-deficient mice would appear to be respon-
sible for the overall general health. However, certain immune
responses appear to be critically dependent on an intact
cross-presentation pathway, such as the rejection of syngeneic
fibrosarcoma, which is completely defective in Batf3-deficient
mice (Hildner et al., 2008). Until now, studies of Batf3-deficientmice have largely focused on features of the adaptive immune
response rather than examining innate immunity. Therefore,
the present study identifies a critical role unique for the CD8a+
DC in innate immune responses against pathogens in vivo.
The role of CD8a+ DCs in protection against T. gondii infection
was previously suggested through the observation that this
subset is the major cell type to produce IL-12 in response to
intravenous administration of T. gondii antigen STAg (Reis e
Sousa et al., 1997). Furthermore, CD8a+ DCs express Tlr11 at
much higher concentrations than CD8a DCs (Yarovinsky
et al., 2005), neutrophils, and monocytes. However, pDCs also
express Tlr11 (Pepper et al., 2008), so that the correlation
between sensitivity to activation by T. gondiidoes not exclusively
identify the CD8a+ DC as the main responder. Thus, no clear
evidence previously was able to uniquely identify the CD8a+
DC as a cell type required for controlling T. gondii infection
in vivo. In addition, although Tlr11-deficient mice show impaired
IL-12 production after infection by T. gondii (Yarovinsky et al.,
2005), these mice show only a modest change in susceptibility
compared to the dramatic increase seen in Myd88-deficient
mice (Scanga et al., 2002), implying that additional sensors for
T. gondii infection may exist. Our data strongly demonstrate
that the CD8a+ DC is themain cell induced to produce IL-12 after
acute challenge with T. gondii tachyzoites, which agrees with
selective expression of TLR11 and potentially other uncharacter-
ized T. gondii-specific sensors by this cell type. Nonetheless,
other DC subsets may dominate in infections initiated by
T. gondii cysts in the peritoneal cavity (data not shown).
It is unclear what advantage the immune system gains from
limiting either cross-presentation or the production of IL-12
during infection to a single subset of dendritic cells. On the one
hand, if cross-presentation is an important requirement for
generation of CD8+ T cell responses against intracellular patho-
gens, one might reason that allowing all dendritic cells to exer-
cise this function in vivo would better suit robust CTL responses.
On the other hand, it is unclear what advantage the immune
system gains by restricting IL-12 production in response to
T. gondii infection to a single subset. CD8a+ DCs, which possess
both peripheral and lymphoid resident populations, clearly
express a unique pattern of innate sensors that distinguish these
cells from other populations of conventional DCs and macro-
phage and/or monocytes subsets. Conceivably, restricting
production of IL-12 to this unique subset could act to limit immu-
nopathology that may derive from overproduction of IL-12 during
infection. An example of the importance of this balance between
immune activation and control is seen in the Il10-deficient mice,
which succumb to T. gondii infection resulting from immunopa-
thology caused by overproduction of IL-12 (Gazzinelli et al.,
1996). Whatever the reasons, the present results clearly demon-
strate a second critical function in vivo for the CD8a+ DC, in
which selective activation of CD8a+ DCs and their subsequent
production of IL-12 is a major pathway leading to early IFN-g-
mediated control of Toxoplasma gondii infection.EXPERIMENTAL PROCEDURES
Mice
Wild-type 129S6/SvEv, BALB/c, C57BL/6, and B6.SJL mice were originally
purchased from Taconic and then bred in-house for experimental use.Immunity 35, 249–259, August 26, 2011 ª2011 Elsevier Inc. 257
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CD8a+ DCs Are Critical in T. gondii InfectionC57BL/6 Rag2/ mice were purchased from Taconic. Il12a/ mice were
purchased from Jackson Labs on both C57BL/6 and BALB/c backgrounds.
Additional experimental C57BL/6 and B6.SJL mice were also purchased
from Jackson Labs. Some experiments on the BALB/c background were
done with C.Cg-Foxp3tm2Tch/J purchased from Jackson Labs that express
an IRES-EGFP downstream of the Foxp3 gene; these mice were used as
wild-type controls. Batf3/ mice were previously generated in our laboratory
(Hildner et al., 2008) on a 129S6/SvEv background and subsequently
backcrossed for 10 generations onto both C57BL/6 and BALB/c back-
grounds. Mice were age and sex matched for each experiment and were
generally between 8 and 15 weeks old. All mice were maintained under
specific-pathogen-free conditions according to institutional guidelines and
with protocols approved by the Animal Studies Committee of Washington
University.
Parasites and Infections
The type II Prugniaud strain of T. gondii expressing a firefly luciferase and GFP
transgene (PRU-FLuc-GFP) (provided by J. Boothroyd, Stanford University,
Palo Alto, CA) was used in all tachyzoite experiments. The parasites were
grown in culture in human foreskin fibroblasts as previously described (Rob-
ben et al., 2004). For infections, freshly egressed parasites were filtered,
counted, and injected intraperitoneally into mice. C57BL/6, 129S6/SvEv,
and BALB/c mice were infected with 100, 200, and 1,000 tachyzoites, respec-
tively, for most experiments. BALB/c mice used for tetramer studies were in-
fected with 5,000 tachyzoites. BALB/c bone marrow chimeras and controls
were infected with 100 tachyzoites.
Cell Preparation
For all experiments except tetramer analysis, spleens were digested in 5 mL
Iscove’s Modified Dulbecco’s Media (IMDM, Invitrogen) containing 10% fetal
calf serum (HyClone) with 250 mg/mL collagenase B (Roche) and 30 U/mL
DNase I (Sigma-Aldrich) for 1 hr at 37C with agitation via stir-bars. For exper-
iments analyzing intracellular cytokines, brefeldin A was added at 1 mg/mL
during collagenase B and DNase I treatment, after which the cells were incu-
bated for an additional 3 hr in IMDM with brefeldin A. Red blood cells were
lysed by incubation in ACK lysis buffer. Cells were filtered through 80 mm
strainers and counted on an analyzer (Vi-CELL, Beckman Coulter). 1–5 3
106 cells were stained for flow cytometric analysis.
For T cell analysis via tetramers, spleens were disrupted in 2 mL ACK lysis
buffer, filtered through 80 mm strainers, and counted on a Vi-CELL analyzer.
1–3 3 106 cells were stained for flow cytometric analysis.
For analysis of peritoneal cells, a peritoneal lavage was performed with
10 mL Dulbecco’s PBS (DPBS). Harvested cells were lysed in ACK buffer,
filtered, counted, and stained for flow cytometry.
Flow Cytometry
Cells were incubated for 5 min at 4Cwith Fc Block (clone 2.4G2, BD) in FACS
buffer (DPBS + 0.5%BSA + 2mMEDTA). Dead cells were excluded with LIVE/
DEAD Aqua Fixable Dead Cell Stain Kit (Invitrogen). Surface staining was done
for 20 min at 4C in FACS buffer. For tetramer staining, cells were incubated in
the presence of tetramer and surface antibodies for 45 min at 4C. Absolute
cell numbers were calculated with the total cell count multiplied successively
by the percentages for the appropriate gates obtained through flow cytometry.
Cells were analyzed on a BD FACSCantoII flow cytometer and data analyzed
with FlowJo software (Tree star, Inc.).
Intracellular Cytokine Staining
For intracellular cytokine staining, cells were first surface stained, then fixed in
2% paraformaldehyde for 15 min at room temperature. Cells were then resus-
pended in permeabilization buffer (DPBS + 0.1% BSA + 0.5% saponin) and
stained with anti-IL-12p40 or anti-IFN-g for 30 min at 4C.
In Vitro T Cell Restimulation
4 3 106 splenocytes from day 8 infected mice were incubated overnight in
100 ml cIMDM with 100 mg/mL GRA4 peptide (SPMNGGYYM). Brefeldin A at
1 mg/mL was added during the last 4 hr of incubation. Cells were then har-
vested and analyzed for IFN-g production with the intracellular cytokine stain-
ing protocol described above.258 Immunity 35, 249–259, August 26, 2011 ª2011 Elsevier Inc.Luciferase Imaging
Imaging was done as previously described (Saeij et al., 2005). In brief, mice
were given intraperitoneal injections of D-Luciferin (Biosynth AG, Switzerland)
at 150 mg/kg and allowed to remain active for 5 min. Animals were then anes-
thetized with 2% isoflurane for 5 min and then imaged with a Xenogen IVIS 200
machine (Caliper Life Sciences). Data were analyzed with the Living Image
software (Caliper Life Sciences).
ELISA and CBA
IL-12p40 concentration was measured from serum samples with the Mouse
IL-12p40 OptEIA ELISA set (BD Bioscience). IFN-g serum concentration was
measured with the BD CBA Mouse Inflammation Kit (BD Biosciences), and
data were analyzed with FCAP Array software (Soft Flow, Inc. USA).
Administration of IL-12
Recombinant murine IL-12 (Peprotech) was resuspended in pyrogen-free
saline at a concentration of 2.5 mg/mL, aliquoted, and frozen at 80C. Mice
were injected i.p. with 0.5 mg of IL-12 on days 0, 1, 2, 3, and 4 after infection.
BM Chimera Generation
This experimentwas performed once onmice on theC57BL/6 background and
once onmice on the BALB/c background. Bonemarrow from femurs and tibias
were harvested, red blood cells lysed in ACK lysis buffer, filtered through 80 mm
strainers, and counted with the Vi-CELL analyzer (Vi-CELL, Beckman Coulter).
Recipient mice were irradiated with 800 (BALB/c) or 1,200 (C57BL/6) rads of
whole body irradiation. In the experiment with C57BL/6 mice, all recipients
were WT C57BL/6 or B6.SJL. In the experiment with BALB/c mice, WT recip-
ients were used for the WT donor BM condition, whereas Batf3/ recipients
were used for the Batf3/, WT + Batf3/, and Il12a/ + Batf3/ donor
BM conditions. The day after irradiation, the recipients were injected intrave-
nously with 2–4 million bone marrow cells from either a single donor or a 1:1
mixture from two donors. Mice were allowed to reconstitute for 10 (C57BL/6)
to 18 (BALB/c) weeks after transfer and subsequently bled to determine chime-
rism. In experiments with C57BL/6 mice, the congenic markers CD45.1 and
CD45.2 were used to determine percent chimerism via flow cytometry. In
experiments with BALB/c mice, male/female donors were mixed to allow for
analysis of chimerismwith the Y chromosome. Peripheral blood from chimeras
was lysed for genomic DNA and analyzed by quantitative real-time PCR for the
presence of the gene Zfy1 on the Y chromosome with the following primers:
Zfy1 (encoding zinc finger protein 1): Zfy1-forward, 50-GCGTATCCTCATA
AATGTGAC-30, and Zfy1-reverse, 50-CATCTCTTACACTTGAATGG-30. Rag2
(encoding recombination activation gene 2) was used as a normalization
control, Rag2-forward, 50-GGGAGGACACTCACTTGCCAGTA-30, and Rag2-
reverse, 50-AGTCAGGAGTCTCCATCTCACTGA-30. Known mixtures of male-
to-female DNA were used to generate a standard curve (100%, 60%, 50%,
and 40% male DNA) and to determine the percent of male DNA per sample.
Statistics
For analyses of survival data, the log-rank test was used. For analyses of all
other data, an unpaired, two-tailed Student’s t test with a 95% confidence
interval was used (Prism; GraphPad Software, Inc.). All data are represented
as means ± SD.
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